Failures of zidovudine postexposure prophylaxis

American Journal of Medicine

Volumn 102, Issue 5 B, 1997, Pages 52-55

  Jochimsen, Elise M ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HEALTH CARE PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; TREATMENT FAILURE;

ANTI-HIV AGENTS; HEALTH PERSONNEL; HIV INFECTIONS; HUMANS; OCCUPATIONAL EXPOSURE; TIME FACTORS; TREATMENT FAILURE; ZIDOVUDINE;

EID: 0030871249     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00062-4     Document Type: Conference Paper

References (20)

1. Tokars JI, Marcus R, Culver DH, et al. Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. Ann Intern Med. 1993;118:913-919.
2. Centers for Disease Control and Prevention. Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood - France, United Kingdom, and United States, January 1988-August 1994. MMWR. 1995;44:929-933.
3. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 1994;331:1173-1180.
4. Niu MT, Stein DS, Schnittmann SM. Primary human immunodeficiency virus type 1 infection: review of pathogenesis and early treatment interventions in humans and animal retrovirus infections. J Infect Dis. 1993;168:1490-1501.
5. Gerberding JL. Management of occupational exposures to blood-borne viruses. N Engl J Med. 1995;332:35-37.
6. Tait DR, Pudfin DJ, Gathiram V, Windsor IM. HIV seroconversions in health-care workers, Natal, South Africa. (Abstr.) Program and Abstracts of the 8th International Conference on AIDS, Amsterdam, 1992:PoC 4141.
7. Anonymous. HIV seroconversion after occupational exposure despite early prophylactic zidovudine therapy. Lancet. 1993;341:1077-1078.
8. Lot F, Abiteboul D. Infections professionnelles par le V.I.H. en France: le point au 31 mars 1992. Bulletin Epidemiologique Hebdomadaire (Paris). 1992;26:117-119.
9. Looke DFM, Grove DI. Failed prophylactic zidovudine after needlestick injury. (Letter.) Lancet. 1990;335:1280.
10. Heptonstall J, Gill ON. HIV, occupational exposure, and medical responsibilities. (Letter.) Lancet. 1995;346:578-579.
11. Brun-Vezinet F, Ingrand D, Deforges L, et al. HIV-1 sensitivity to zidovudine: a consensus culture technique validated by genotypic analysis of the reverse transcriptase. J Virol Methods. 1992;37:177-188.
12. Pratt RD, Shapiro JF, McKinney N, Kwok S, Spector SA. Virologic characterization of primary human immunodeficiency virus type 1 infection in a health care worker following needlestick injury. J Inf Dis. 1995;172:851-854.
13. Centers for Disease Control and Prevention. Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use. MMWR. 1990;39(RR-1):1-14.
14. Durand E, LeJeunne C, Hughes F. Failure of prophylactic zidovudine after suicidal self-inoculation of HIV-infected blood. (Letter.) N Engl J Med. 1991;324:1062.
15. Jones PD. HIV transmission by stabbing despite zidovudine prophylaxis. (Letter.) Lancet. 1991;338:884.
16. Larder BA, Chesebro B, Richman DD. Susceptibilities of zidovudine-susceptible and resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assay. Antimicrob Agents Chemother. 1990;34:436-441.
17. Lange JMA, Boucher CAB, Hollak CEM, et al. Failure of zidovudine prophylaxis after accidental exposure to HIV-1. N Engl J Med. 1990;322:1375-1377.
18. Centers for Disease Control and Prevention. Patient exposures to HIV during nuclear medicine procedures. MMWR. 1992;41:575-578.
19. Palmer DL, Hjelle BL, Wiley CA, et al. HIV-1 infection despite immediate combination antiviral therapy after infusion of contaminated white cells. Am J Med. 1994;97:289-295.
20. Ho DD, Mougil T, Alam M. Quantitation of HIV type 1 in the blood of infected persons. N Engl J Med. 1989;321:1621-1625.